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4. Self-Esteem Instability in Current, Remitted, 






Self-esteem (i.e., global self-esteem, ESE) has not only been observed as 
being generally low in major depressive disorder (MDD) and anxiety 
disorders (AD), but also being relatively unstable (i.e., low self-esteem 
stability; SE-S). Low SE-S, potentially regardless of ESE, may be a crucial 
maintaining factor of MDD and AD due to increased vulnerability to daily 
stress and minor forms of perceived rejection. However, few studies have 
looked at SE-S in clinical samples, and none have differentiated between 
remittance and recovery to see whether low SE-S is persistent shortly and 
long after an episode. Therefore, the present study compared self-reported 
SE-S across current MDD (n = 60), AD (n = 111), and comorbid MDD/AD (n = 
71), remitted MDD (n = 41), AD (n = 29), and comorbid MDD/AD (n = 14), 
recovered MDD (n = 136) and AD (n = 98), and never MDD or AD 
comparison group (n = 382). SE-S and ESE were measured by means of a 
self-report questionnaire. The comparison group had higher SE-S than all 
other clinical groups. Once controlling for ESE, differences with current 
MDD/AD, remitted MDD, and recovered MDD/AD remained, but 
disappeared for the comorbid groups. The current findings are consistent 
with the view that not only enduring low self-esteem per se, but also high 
self-esteem reactivity to external events may contribute to the development 
or maintenance of affective disorders. Further, such reactivity appears to 
persist into remittance and recovery which may contribute to the increased 
risk of relapse. 
Keywords: self-esteem, instability, anxiety, depression, comorbidity 
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Low global self-esteem (ESE2; i.e., the degree that one values oneself 
irrespective of specific context) is a prominent aspect in most explanatory 
and causal models of major depressive disorder (MDD) and anxiety disorders 
(AD; Beck, 2002). Indeed, research has consistently found low levels of ESE in 
clinical samples (e.g., Orvaschel et al., 1997; Silverstone, 1991). Low ESE 
appears to precede increases in symptomatology suggesting a potential 
causal role (Sowislo & Orth, 2013). Many studies show that ESE is mostly 
consistent over the life span, with slight increases observed from 
adolescence to young adulthood, and middle age, before starting to 
decrease in old age (Orth & Robins, 2014). However, the extent of change in 
levels of self-esteem from moment-to-moment appears to vary between 
persons. Self-esteem stability (SE-S) refers to the extent and frequency of 
short-term self-esteem fluctuations usually in response to mood states 
(Clasen et al., 2015; Roberts & Monroe, 1994) or positive and negative daily 
situations (Kernis et al., 1991). This is somewhat in keeping with diathesis-
stress models of depression and anxiety that highlight that those who are 
more vulnerable will react stronger to external factors, or require less 
intensity to gain a reaction (Zuckerman, 1999). With regards to MDD and AD, 
some have argued that low levels of baseline self-esteem (i.e., low ESE) are 
not a prominent aspect per se (e.g., Franck & De Raedt, 2007), but rather the 
degree and frequency of fluctuation from this baseline level (i.e., low SE-S; 
also known as unstable self-esteem or self-esteem instability). While ESE 
might be considered to reflect trait self-esteem, given the relevant consistent 
level which provides a self-esteem baseline across situations, SE-S is 
relatively state-like, with possible reactions to external situations and stimuli, 
and the potential for it to swing. 
 Prior studies looking at SE-S have been conducted using student 
samples with a focus on depressive symptomatology, and the results are 
inconsistent. Some found that SE-S was a better predictor of depressive 
symptoms than ESE (Roberts & Monroe, 1992), some found an interaction 
                                                     
2 For consistency in this thesis, ESE is used to denote global (trait) self-esteem as the 
two constructs are measured with the same questionnaires. However, in the absence 
of implicit measures, previous research normally does not specifically state the 
explicit aspect of global/trait self-esteem. This is not to say that ISE only occurs at the 





between SE-S and ESE in predicting symptoms (de Man et al., 2001; Kernis et 
al., 1991; study 1, Roberts et al., 1995), while others failed to find the 
predictive validity of SE-S over and above ESE (study 2 & 3, Roberts et al., 
1995). Given that the mean level of depressive symptoms in student samples 
are often very low, it is unclear how these findings relate to clinical samples 
of MDD or AD based on the few clinical studies conducted. Low SE-S was 
observed in social anxiety disorder, but this disappeared when ESE was taken 
into account suggesting that ESE was key to differentiating between those 
with and without a social anxiety disorder (Farmer & Kashdan, 2014). 
Individuals with a current MDD reported lower SE-S than a never-depressed 
comparison group, and similar levels of SE-S as those who previously met 
the criteria for an MDD (Franck & De Raedt, 2007). However, ESE was not 
controlled for in this study. Longitudinal analysis revealed that SE-S was 
related to symptoms 6 months later in the never-depressed comparison 
group and former MDD, while ESE and an interaction between the two were 
not (Franck & De Raedt, 2007). Research conducted till now seem to support 
the hypothesis that SE-S plays a role in MDD, either in addition to, or in an 
interaction with, ESE. Given the lack of relevant studies, the case for AD is 
weak, and it is unclear as to whether MDD and AD may differ in level of SE-S. 
As comorbid MDD and AD have previously shown to have lower levels of ESE 
than those with either an MDD or AD only (van Tuijl et al., 2016), it is feasible 
that SE-S may also be lower in the comorbid group which may explain the 
poorer rate of remittance (Penninx et al., 2011). Therefore, the first aim of the 
present study was to compare levels of SE-S between MDD, AD, co-morbid 
MDD and AD, and a never depressed or anxious comparison group (i.e., the 
comparison group). 
Many studies report a significant positive relationship between ESE 
and SE-S (Okada, 2010), which is in keeping with assumptions concerning the 
relationship between trait and state levels of self-esteem in the sociometer 
theory (Leary & Baumeister, 2000). This theory postulates that individuals 
with high (trait) self-esteem are less likely to lower their self-esteem in 
response to rejection (state self-esteem), due to high expectations of being 
accepted. Indeed, this is mirrored somewhat by the finding that those with 
higher ESE are more likely to report more stable levels of self-esteem (Okada, 
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2010). The second aim of the present study, therefore, was to compare SE-S 
across clinical groups and a comparison group while correcting for ESE. 
Further, to test the possibility that SE-S is relevant only when ESE is low, the 
interaction between ESE and SE-S is explored in predicting symptoms of 
depression and anxiety. 
High relapse and recurrence rates are often reported in MDD and 
AD. This has fuelled several scarring hypotheses that argue that following 
periods of symptomatology, residual cognitions like low self-esteem remain 
that increase vulnerability for relapse (Lewinsohn et al., 1981). Indeed, lower 
levels of ESE were observed in remitted and recovered AD and MDD when 
compared to those who had never been diagnosed with a depressive or 
anxiety disorder (van Tuijl et al., 2016). The notion that remaining scars lie 
dormant and can be activated by mild sad moods (Gemar et al., 2001; Segal, 
Gemar, & Williams, 1999), should mean that recovered and remitted MDD 
and AD are likely to report lower SE-S than the comparison group, even 
when controlling for ESE. Former MDD showed lower SE-S than a never-
depressed comparison group, and similar levels as current MDD (Franck & 
De Raedt, 2007). However, the former MDD group did not differentiate 
between those who were in remittance (i.e., recently experienced an episode) 
and those who were recovered. It is feasible that scars continue to heal after 
an episode of MDD. Further, no studies have included clinical groups of 
remitted and recovered AD. Therefore, the present study differentiated 
within the clinical groups (MDD, AD and comorbid) between those who 
currently met the criteria for the disorder, those who were current in 
remission, and those who had recovered (for MDD and AD only). 
Method 
Participants  
Participants were recruited from community, primary care and 
mental health organisations into the Netherlands Study of Depression and 
Anxiety (NESDA; www.nesda.nl/) if they currently had a depressive disorder 
or AD (n = 1701), were at risk of developing a disorder (e.g., family member 
with a depression) or had a life-time diagnosis (n = 907). A further 373 





as a comparison group. Baseline measures took place in 2004-2007 (N = 
2981), and have been followed up biannually on several measurements. At 
baseline, exclusion criteria were: a) Primary diagnosis of other psychiatric 
disorders such as psychotic disorder, an obsessive-compulsive disorder, a 
bipolar disorder, or a severe addiction; b) Non-fluent command of the Dutch 
language (Penninx et al., 2008). The present study makes use of data 
collected at the six-year follow-up. There was a 24% attrition rate at this 
wave since baseline (N = 2256 remaining), and 1799 received the self-esteem 
measures (age range 23 – 72, M = 48.05, SD = 13.18; 63.6% female). 
Incomplete participation (i.e., no self-esteem measures given; n = 457) 
occurred for various technical and practical reasons (e.g., participation via 
telephone).  A further 83 participants were excluded as they met the criteria 
for a bipolar disorder during the study, or reported an alcohol dependence 
since the last interview. All participants provided written consent, and ethical 
approval was granted by all participating universities.  
The same clinical groups were used as in van Tuijl et al., 2016 (and 
Chapter three). To recap, clinical groups were formed based on answers 
given on the Composite International Diagnostic Interview (v2.1; CIDI; Robins 
et al., 1988; Wittchen, 1994). The CIDI is a semi-structured interview 
conducted by trained staff to determine depressive and anxiety disorders. 
Diagnosis of MDD, dysthymia, panic disorder (with and without 
agoraphobia), generalized anxiety disorder, social anxiety and agoraphobia 
were determined based on the criterion outlined in the DSM-IV. Information 
concerning disorder diagnosis and recency (when symptoms ceased) was 
used to form the different clinical groups (for more detail see van Tuijl et al., 
2016). In brief, MDD and AD clinical groups were split by those currently in 
an episode (diagnosis in past month), those in remission (an episode that 
had ended in the last six - one month), and those recovered (an episode in 
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the last seven years – six months)3. In order to establish relatively pure MDD, 
those who had also met the criteria for AD since the last interview were 
excluded (n = 162). Likewise, participants who had a current AD and also met 
the criteria for any depressive disorder (e.g., MDD, dysthymia) since the last 
interview were excluded (n = 123). Those in the recovered AD or MDD 
groups had no history of MDD (and dysthymia) or AD, respectively. Current 
and remitted comorbid AD and MDD groups were also formed based on the 
same criteria as the MDD and AD groups. Participants who have no history of 
AD, MDD or dysthymia formed the comparison group. The upper half of 
Table 4.1 provides an overview of the demographics and size of each group. 
Measures 
Beck Anxiety Inventory (BAI; Beck et al., 1988). The BAI is a self-
report questionnaire containing 21 anxiety symptoms. The degree of 
disturbance in the past week was answered on a 4-point Likert scale from 1 
(Not at all) to 4 (Severely [I could barely stand it]). Higher total scores were 
indicative of more anxious symptoms. Missing answers were replaced with 
participant’s mean response (n = 47). From the 1799 participants, 33 
participants were excluded from any analysis involving the BAI (29 failed to 
return the questionnaire and four had more than nine missing answers). The 
BAI showed excellent internal reliability across all those without missing 
answers (n = 2084; Cronbach’s α = .92). 
Inventory of Depressive Symptomatology – self-report (IDS: 
Rush et al., 1986). A self-report IDS was used to measure the severity of 
depressive symptoms in the last week, based on the DSM-IV criteria for 
MDD. Twenty eight items (e.g., “Feeling sad”) were answered with four 
options where “0” indicated no depression (e.g., “I do not feel sad”) and “3” 
referred to a severe depressive symptom (e.g., “I feel sad nearly all the time”). 
                                                     
3 We used these cut-offs as these were more readily available within the study. It 
should be noted that what defines, for example, a depression in remission varies 
across studies. Frank et al. (1991) recommends that remission be considered as a 
depression-free period of 2-6 months, with longer than 6 months considered a 
recovery. Our cut-offs are not too far from this. Cut-offs for ADs are dependent on 
the type of AD, however we apply the same cut-offs as used for MDD for consistency 





Higher total scores were indicative of relatively severe depressive 
symptomatology. From the 1799 participants, 32 were excluded from any 
analysis involving the IDS (29 failed to return the questionnaire and three 
had too many missing answers [>6 items]). The IDS showed excellent internal 
reliability across all those without missing answers (n = 2150; Cronbach’s α = 
.90). 
 Rosenberg Self-Esteem Scale (Rosenberg, 1989). A self-report 
questionnaire containing 10 items was used to measure global self-esteem. 
Answers were given on a 4-point Likert scale from 1 (strongly agree) to 4 
(strongly disagree). Higher scores were indicative of higher explicit self-
esteem. Excellent internal reliability was observed in the present study 
(Cronbach’s α = .92). 
 Self-Esteem Stability. Two items from a five-item Self-Esteem 
Instability Scale were administered to measure self-esteem stability: “How 
much I value myself is subject to changes” and “How much I value myself is 
stable across several situations at various times”4. A four-item version was 
previously validated (Raes & Gucht, 2009). Answers to both questions were 
answered on a 5-point Likert scale from 1 (“completely does not apply to 
me”) to 5 (“completely applies to me”). Higher scores were indicative of more 
stable self-esteem, based on total scores following the reversal of the answer 
to the first question. The two questions were significantly correlated, r(1797) 
= .38, p <.001. The relatively low correlation indicated that both questions 
were also partly complementary. 
 
 
                                                     
4 In the interest of keeping NESDA measurements as concise as possible, two items 
were selected based on face validity that they related to the conceptual 
understanding of self-esteem stability, and were not completely overlapping. As such, 
a positively phrased item and a negatively phrase item were selected. Excluded items 
were “The extent to which I value myself may vary at different times”, “A certain event 
can make me value myself more, or less than how much I valued myself before the 
event.” and “I often switch between ‘feeling extremely positive about myself’ and 
‘seeing only the bad things about myself, and feeling like a failure”. 




 NESDA assessments take between three and five hours, and are 
completed in one sitting (see Penninx et al., 2008). Assessments contain 
computer tasks, self-report questionnaires, interviews, and biological 
measures carried out by trained staff. Participants received travel expenses 
and a 15-euro gift certificate. 
Statistical Analysis 
 Bivariate correlations between SE-S and ESE, IDS, and BAI were 
calculated. Other possible correlations have been reported previously 
(chapter 3; van Tuijl et al., 2016). In the first part of the analysis, an ANOVA 
was conducted to compare SE-S across groups (i.e., current/ 
remitted/recovered MDD, current/remitted/recovered AD, current/remitted 
comorbidity and the comparison group). This analysis was then repeated 
with ESE as a covariate. In the second part of the analysis, two multiple 
regression analysis were conducted to predict variance in IDS scores (n = 
1574) and variance in BAI scores (n = 1572). In both models, ESE scores and 
SE-S scores (both standardized) were entered at step 1. At step 2, the 
interaction between standardized ESE and SE-S scores was entered. 
Following a residual analysis, extreme residuals (±3.3) were removed before 
re-running the analysis to improve the fit of the model. Two-way interactions 
were probed using a method outlined by Dawson (2014), and Aiken and 
West (1991). Slopes were tested at ± 1 SD of ESE. 
Results 
Descriptives 
 Mean age, BAI, IDS, ESE, and SE-S scores, and the percentage 
females, per group, are presented in Table 4.1. Based on Spearmans Rho, SE-
S scores were significantly related to ESE, ρ(1714) = .67, p<.001, IDS, ρ(1685) 
= -.51, p <.001, and BAI, ρ(1684) = -.44, p<.001. In other words, relatively 
high SE-S was associated with higher ESE, and less depression and anxiety 
symptomatology. Previous missing data analysis highlighted that those who 





have higher BAI (d = 0.28) and IDS (d = 0.25) scores than completers (n = 
1799; van Tuijl et al., 2016). 
 To explore differences in SE-S between types of AD, a one-way 
ANOVA was conducted. Participants were excluded from this analysis if 
another AD was present in the previous six months (i.e., comorbidity within 
AD). Groups were formed based on the current presence of a social anxiety 
disorder (n = 35), panic disorder (with or without agoraphobia; n = 21), 
agoraphobia (n = 26), and general anxiety disorder (n = 9). Results indicated 
that there was no difference between AD types in SE-S, F(3, 87) = 1.31, p = 
.28, partial η2 = .04, thus supporting one current AD group incorporating all 
AD types. Conclusions were the same both when BAI scores and ESE scores 
were statistically controlled for. 
Self-Esteem Stability between Groups 
A one-way ANOVA comparing scores on the SE-S across groups was 
significant, F(8.941) = 45.82, p <.001. Levene’s test was significant (p = .03), 
and group sizes were unequal, thus Games-Howell post-hoc ANOVA 
comparisons were conducted. The comparison group had higher SE-S than 
all current and remitted clinical groups (d’s 1.04 – 1.60), and those who had 
recovered from MDD (d = 0.66, 95% CI [0.48, 0.99]) and AD (d = 0.78, 95% CI 
[0.60, 1.11]). Those who had recovered from MDD, and those who had 
recovered from AD, had higher SE-S than all other clinical groups (d’s 0.44 - 
0.90) apart from remitted AD (p = .64 & p = .91, respectively). Recovered 
MDD and AD did not differ from one another in SE-S (p = .999). There were 
no further differences (p’s > .14). 
The one-way ANOVA was repeated with ESE as a covariate, to see 
whether earlier differences between SE-S remained when correcting for ESE, 
and was significant, F(9,932) = 97.35, p <.001, partial η2 = .49. With ESE as a 
significant covariate, F(1,932) = 366.12, p<.001, partial η2 = .28, there was a 
significant effect of group, F(8,932) = 6.42, p<.001, partial η2 = .05. As 
Levene’s test was significant, F(8, 933) = 2.36, p = .02, and group sizes 
unequal, more conservative Bonferroni post-hoc ANCOVA comparisons were 
conducted (estimated marginal means reported in Table 4.1). In correcting 
for differences in ESE, the comparison group still had higher SE-S than 
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current MDD (p=.01), remitted MDD (p<.001), current AD (p=.002), 
recovered MDD (p=.001) and recovered AD (p = .01). There were no further 
differences (p’s >.08). 
Interaction between SE-S and ESE, and Symptomatology 
In predicting symptoms of depression, seven extreme residuals were 
removed before running the analysis. With the inclusion of ESE and SE-S 
scores at step one, the model was significant, F(2, 1677) = 755.96, p<.001 
and predicted 47% of variance in IDS scores (adjusted R2 = .47). At this step, 
both ESE (B = -6.93, SE = .25, p<.001, semi-partial r = -.49) and SE-S (B = -
0.62, SE = .25, p = .01, semi-partial r = -.04) were significant coefficients in 
the model. With the inclusion of the interaction between SE-S and ESE, the 
model improved, F-change (1, 1676) = 17.08, p<.001, and now predicted 
48% of variance in scores (adjusted R2 = .48; final model - F (3, 1676) = 
514.50, p <.001). Both ESE (B = -6.79, SE = .25, p<.001, semi-partial r = -.48) 
and SE-S scores (B = -0.78, SE = .25, p = .002, semi-partial r = -.06) remained 
significant coefficients. Also the interaction between ESE and SE-S was a 
significant factor in the model, B = 0.77, SE = .19, p<.001, semi-partial r = 
.07. The interaction is plotted in Figure 4.1, and simple slopes revealed that 
when ESE was high (+1 SD), there was no difference in IDS score across 
low/high SE-S, gradient of slope = -0.01, t = -.04, p = .97. However, when 
ESE was low (-1 SD), the slope was significant, gradient of slope = -1.55, t = -
4.63, p <.001, suggesting that those with lower SE-S reported higher IDS 
scores than those with higher SE-S. 
In predicting symptoms of anxiety, 21 extreme residuals were 
removed before rerunning the analysis. At step one, the model was 
significant, F(2, 1662) = 355.27, p<.001, and predicted 30% of variance in BAI 
scores (adjusted R2 = .30). Both ESE (B = -3.42, SE = .19, p<.001, semi-partial 
r = -.37) and SE-S scores (B = -0.58, SE = .19, p = .002, semi-partial r = -.06) 
were significant coefficients in this model. With the inclusion of the 
interaction between SE-S and ESE, improved the model slightly, F-change (1, 
1661) = 4.59, p = .03, and still accounted for 30% of variance in BAI scores 
(adjusted R2 = .30; final model - F(3, 1661) = 238.89, p<.001). Both ESE, B = -





.19, p = .001, semi-partial r = -.07, remained significant coefficients in the 
model. The interaction between ESE and SE-S was also significant, B = 0.30, 
SE = .14, p = .03, semi-partial r = .04, and is plotted in Figure 4.2. Simple 
slopes revealed that when ESE was high (+1 SD), there was no difference in 
BAI score across low/high SE-S (gradient of slope = -0.34, t = -1.53, p = .13). 
However, when ESE was low (-1 SD), the slope was significant (gradient of 
slope = -0.95, t = -3.71, p <.001), suggesting that those with lower SE-S 
reported higher BAI scores than those with higher SE-S. 
 
 
Figure 4.1. The two-way interaction between high and low (± 1 SD) ESE 
(global self-esteem as measured by Rosenberg Self-Esteem Scale) and SE-S 










































* p <.001 
n.s = non-
significant 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.2. The two-way interaction between high and low (± 1 SD) E-SE 
(global self-esteem as measured by Rosenberg Self-Esteem Scale) and SE-S 
(self-esteem stability) scores in the prediction of anxiety symptoms (N = 
1665). 
Discussion 
The main findings of the present study can be summed as follows: i) 
The comparison group showed higher SE-S than all current, remitted, and 
recovered clinical groups, whereas recovered AD and MDD showed higher 
SE-S than all other clinical groups; ii) For current MDD, current AD, remitted 
MDD, recovered MDD, and recovered AD, these differences in SE-S with the 
comparison group remained when correcting for ESE; ii) Particularly when 
ESE was low, symptoms of both depression and anxiety were related to low 
SE-S. 
 Self-esteem stability was lower in all clinical groups in contrast to the 
comparison group. This is in keeping with the previous studies who have 
found low SE-S in current MDD and AD (Farmer & Kashdan, 2014; Franck & 
De Raedt, 2007), and is consistent with previous studies focusing on 
analogue student samples (e.g., de Man et al., 2001). = The current findings 
extend those of Franck and De Raedt (2007) by highlighting that even when 




























* p <.001 
n.s = non-
significant 
Self-esteem Stability, Depression, and Anxiety 
91 
 
recovered MDD. Moreover, low SE-S was also observed in the current AD 
group in the present sample, even when correcting for ESE. The latter is in 
contradiction with Farmer and Kashdan (2014) who found that the relevance 
of SE-S in social anxiety disorder disappeared when taking ESE into account. 
It seems unlikely that the conflicting findings are explained by broader 
inclusion criteria for AD of the present study since individuals with social 
anxiety disorder did not differ in SE-S from the other ADs. It is possible that 
Famer and Kashdan had less power to detect an effect given the smaller 
sample size, as in the present study the effect sizes were relatively small. 
Also, in Farmer and Kashdan’s sample, 17.5% of the socially anxious 
individuals had a comorbid depression. Differences in comorbidity on SE-S 
were not compared. As such, the presence of a comorbid MDD may (also) 
account for the difference in findings, particularly as SE-S between the 
comparison group and comorbid group did not differ when controlling for 
ESE. 
Differences in SE-S between comorbid MDD/AD and the comparison 
group disappeared once controlling for ESE, but remained for those with 
relatively pure MDD or AD. It is not entirely clear why lower SE-S was 
observed in MDD or AD, but not in comorbid MDD or AD. One explanation 
may lie in differences in ESE. In a previous study, comorbid MDD and AD was 
found to have lower ESE than both those with MDD and those with AD, 
potentially as a result of more persistent and severe symptomatology (van 
Tuijl et al., 2016). It is feasible that when ESE is already extremely low, there is 
little room for fluctuations. In other words, self-esteem cannot drop any 
lower. Likewise, those with relatively high ESE, like those in the comparison 
group, also have little room to fluctuate. As a consequence, the extent of 
instability might be similar between those with very high ESE (i.e., 
comparison group) and those with very low ESE (i.e., comorbid group). 
The combination of low ESE and high SE-S may also explain the 
treatment-resistant nature of comorbidity (Penninx et al., 2011). Some self-
esteem flexibility was argued to be vital for a psychoeducational group 
treatment to be effective, as those with lower SE-S pre-treatment showed a 
larger reduction in depressive symptoms (Roberts, Shapiro, & Gamble, 1999). 





necessary in comorbidity to not only increase ESE that is especially low, but 
also to introduce some flexibility into self-evaluations which may make other 
treatments more effective. Such an intervention may not be necessary for 
those with purer forms of MDD or AD, as common treatments such as 
cognitive behavioural therapy already appear to increase ESE in singular 
forms of these disorders (e.g., Richardson, Stallard, & Velleman, 2010), 
although it is unclear whether SE-S also increases. As such, it seems to be 
vital to differentiate between comorbid MDD/AD and relatively pure 
disorders as comorbidity may be more than simply the sum of MDD and AD 
symptoms. 
 In the present study, differences in SE-S were observed between the 
comparison group and remitted MDD, remitted AD, remitted comorbid, 
recovered MDD and recovered AD. These findings are in keeping with the 
lower SE-S observed in the former MDD group by Franck and De Raedt 
(2007). However, as we did not exclude recovered and remitted MDD with 
residual symptoms, Franck and De Raedt’s findings are extended to highlight 
that low SE-S is present in both remitted and recovered MDD, more broadly. 
The presence of low SE-S in remittance and recovery could be explained in 
terms of a remaining SE-S scar that was a consequence of the episode. 
However, given the cross-sectional nature of the current study, it is just as 
feasible that this “scar” is a remaining prodromal factor that was present 
before the episode in question, or a preceding symptom of the next episode. 
Future longitudinal research should look at whether the extent of low SE-S 
following MDD and AD is predictive of (time to) relapse. Furthermore, scars 
have been hypothesised to lie dormant till activated by life events or 
stressors (Segal et al., 1999). Such stressors need not necessarily be major in 
order to (re-)activate the scars as self-esteem may fluctuate in response to 
subtle changes in mood and daily (minor) life events (Clasen et al., 2015; 
Kernis et al., 1991; Roberts & Monroe, 1994). As such, future longitudinal 
research may want to include a measure of (minor) stressors to see whether 
low SE-S specifically in the presence of stressors predicts relapse. 
 Further support for the differential role of ESE and SE-S in MDD and 
AD comes from the analysis of explaining variance in symptoms across both 
the clinical groups and the comparison group. For both, depressive and 
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anxiety symptomatology, SE-S explained variance over and above ESE, 
although ESE did explain more variance than SE-S. Consistent with the 
findings by De Man, Gutiérrez and Sterk (2001), particularly when ESE was 
low, SE-S was negatively related to depressive and anxiety symptoms. 
Previously, this has been taken to suggest that high SE-S is to some extent a 
protective factor when ESE is low. Indeed, those with more stable levels of 
low ESE may have short-term coping mechanisms when there are threats 
against self-esteem, while those who are reactive to threats may find it more 
difficult to deal with the resulting changes in self-esteem. It is also feasible to 
argue that fluctuations when self-esteem is high are not problematic 
because this may all occur within a positive range. Sociometer theory of self-
esteem suggests that those possessing high self-esteem are less likely to 
react to instances of rejection given that acceptance is anticipated (Leary & 
Baumeister, 2000), as such, fluctuations may occur a lot less when ESE is 
high. Indeed, several studies have highlighted that self-esteem moderated 
responses to rejection (Ford & Collins, 2010). Further, many have reported a 
positive correlation between ESE and SE-S, suggesting that those with higher 
self-esteem are less likely to report instability (Okada, 2010), and this was 
also the case in the present study. Therefore, although there is support for 
distinction between ESE and SE-S, the two also appear to be related. 
 Symptom severity is often found to be a lot higher in comorbid 
depression and anxiety (Penninx et al., 2011). As such, there is some 
contradiction between the observed association between symptoms and SE-
S, and the lack of support that the comorbid group and the comparison 
group differ on the latter. As the analysis dealt with depression and anxiety 
symptoms separately, it is plausible that in the presence of both symptoms, 
SE-S explains no additional variance over and above ESE. This is in keeping 
with theories that comorbid depression and anxiety is more than a sum of 
the parts (Kleiman & Riskind, 2012), and with previous observations of 
differences in another facet of self-esteem (implicit self-esteem) between 
comorbidity and the comparison group, but not with those with more 
singular forms of depression or anxiety (van Tuijl et al., 2016; chapter 3). 
These findings only further justify accounting for the presence of 





complex models as there are several ways in which comorbidity may occur 
(e.g., depression occurring first with anxiety symptoms developing second, 
and vice versa). Further it might be pivotal to acknowledge more complex 
associations between symptoms, ESE and SE-S, which may not be entirely 
linear. It is feasible that SE-S is particularly relevant in distinguishing 
individuals at risk of developing depression or an anxiety disorder when ESE 
levels are mid to low range, and not extremely low or high. 
Another key direction for future studies would be to address the 
assumption that fluctuations in self-esteem are likely to be equal across 
negative and positive events. That is, whether self-esteem that is sensitive to 
negative events like rejection is equally as sensitive to positive events like 
acceptance. SE-S quantified by the standard deviation of multiple 
measurements or self-reported questionnaires like the one used in the 
present study assume this. However, in most contexts “bad is stronger than 
good” (Baumeister, Bratslavsky, Finkenauer, & Vohs, 2001), in that negative 
aspects (e.g., bad feedback) have a larger psychological impact than positive 
aspects (e.g., good feedback). While a previous study has highlighted that 
the extent that self-esteem decreases in reaction to sad mood is related to 
increases in depressive symptomatology (Clasen et al., 2015), it remains to be 
seen whether happy mood is as equally effective in raising self-esteem, and 
thus, reducing depressive symptoms. Given the potential presence of 
anhedonia in depression, it is feasible that the lack of positive-mood reactive 
self-esteem also plays a role in depression. This may also partially explain 
why ESE is low. 
Limitations 
Most previous studies looking at SE-S have quantified this construct 
based on the standard deviation of multiple self-report measures of ESE. This 
method may be less affected by self-report biases which assumedly would 
influence each measurement moment to a similar extent thus having a 
reduced influence on the standard deviation derived. The method employed 
in the current study would more likely be subject to self-report biases, and 
such bias would also affect measures of ESE to a similar degree (e.g., social 
desirability bias would presumably affect two measures concerning the self 
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to an equal extent). However, even when controlling for differences in ESE, 
differences in SE-S were still observed (albeit with small effect sizes), 
suggesting the measure of SE-S tapped into something else. Further, 
quantifying SE-S as is done in the present study also eases comparability. 
Given that previous studies have varied in how often they provide multiple 
measures of ESE (e.g., from weekly to daily), it is unclear what influence this 
may have on scores. Further, it is not clear how skewed scores should be 
dealt with (e.g., participants who often score high, or low), or extreme 
outliers (e.g., a rare good or bad day), both of which influence the mean, and 
subsequently the standard deviation (Baird, Le, & Lucas, 2006). 
The present study adopted a cross-sectional design, and as such, the 
direction of the relationship between SE-S and depression and anxiety 
cannot be established. An important next step would be to test this 
association longitudinally to see whether low SE-S might be a vulnerability 
factor preceding increases in symptoms. In employing a longitudinal design, 
negative life events can also be recorded as many studies using student 
populations suggest that life stressors, particularly of an interpersonal nature, 
decrease SE-S which may increase subsequent depressive symptomatology 
(Hayes, Harris, & Carver, 2004). Such a design may also help differentiate 
between random fluctuations in self-esteem, and fluctuations in response to 
daily events. 
 In conclusion, the present study underlines the presence of self-
esteem instability in clinical groups of MDD and AD. The current findings are 
consistent with the view that not only enduring low self-esteem per se, but 
also high self-esteem reactivity to external events may contribute to the 
development or maintenance of affective disorders. Further, such reactivity 
appears to persist into remittance and recovery which may contribute to the 
increased risk of relapse. From a clinical perspective, these findings highlight 
that interventions should not only aim to increase self-esteem, but also 
ensure that a stable level of self-esteem is achieved. If this is not the case, 
then a minor perceived rejection may undo any intervention effects. 
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